Explore 3 Stock Ideas & Industry Insights Download Free Report

Zero Candida Technologies Inc.

Healthcare CA ZCT

0.175CAD
0.00(0%)

Last update at 2026-06-19T13:30:00Z

Day Range

0.170.17
LowHigh

52 Week Range

0.110.36
LowHigh

Fundamentals

  • Previous Close 0.17
  • Market Cap3.71M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.29

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Income before tax -6.28300M -0.01102M
Minority interest - -
Net income -6.28300M -0.01102M
Selling general administrative 0.96M 0.01M
Selling and marketing expenses - -
Gross profit - -
Reconciled depreciation - -
Ebit - -
Ebitda - -
Depreciation and amortization - -
Non operating income net other - -
Operating income -2.24100M -0.01102M
Other operating expenses - -
Interest expense 0.14M -
Tax provision - -
Interest income 0.10M -
Net interest income -0.04200M -
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense - -
Total revenue 0.00000M 0.00000M
Total operating expenses 2.24M 0.01M
Cost of revenue - -
Total other income expense net -4.00000M -
Discontinued operations - -
Net income from continuing ops -6.28300M -0.01102M
Net income applicable to common shares - -
Preferred stock and other adjustments - -
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Total assets 3.21M 0.00415M
Intangible assets - -
Earning assets - -
Other current assets - -
Total liab 0.87M 0.03M
Total stockholder equity 2.34M -0.02147M
Deferred long term liab - -
Other current liab - -
Common stock - -
Capital stock 0.20M 0.04M
Retained earnings -10.47600M -0.05704M
Other liab - -
Good will - -
Other assets - -
Cash 0.24M 0.00415M
Cash and equivalents - -
Total current liabilities 0.84M 0.03M
Current deferred revenue - -
Net debt 0.00300M 0.00300M
Short term debt - -
Short long term debt 0.00715M 0.00715M
Short long term debt total - -
Other stockholder equity - -
Property plant equipment - -
Total current assets 3.19M 0.00415M
Long term investments - -
Net tangible assets - -
Short term investments 2.81M -
Net receivables - -
Long term debt - -
Inventory - -
Accounts payable 0.00400M -
Total permanent equity - -
Noncontrolling interest in consolidated entity - -
Temporary equity redeemable noncontrolling interests - -
Accumulated other comprehensive income - -
Additional paid in capital - -
Common stock total equity - -
Preferred stock total equity - -
Retained earnings total equity - -
Treasury stock - -
Accumulated amortization - -
Non currrent assets other - -
Deferred long term asset charges - -
Non current assets total 0.03M 0.00000M
Capital lease obligations 0.03M -
Long term debt total - -
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Investments -1.34700M -
Change to liabilities - -
Total cashflows from investing activities - -
Net borrowings 0.00400M -
Total cash from financing activities 2.55M -
Change to operating activities - -
Net income -6.28300M -0.01102M
Change in cash 0.27M -0.00505M
Begin period cash flow 0.17M 0.00919M
End period cash flow 0.24M 0.00442M
Total cash from operating activities -0.94000M -0.00505M
Issuance of capital stock 2.55M -
Depreciation - -
Other cashflows from investing activities - -
Dividends paid - -
Change to inventory - -
Change to account receivables - -
Sale purchase of stock - -
Other cashflows from financing activities - -
Change to netincome - -
Capital expenditures 0.00000M 0.00000M
Change receivables - -
Cash flows other operating - -
Exchange rate changes - -
Cash and cash equivalents changes - -
Change in working capital 0.00560M 0.00597M
Stock based compensation - -
Other non cash items 5.34M -
Free cash flow -0.94000M -0.00505M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
ZCT
Zero Candida Technologies Inc.
- -% 0.17 - - - 2.27
TLT
Theralase Technologies Inc.
-0.005 2.08% 0.23 - - 90.07 82.51 90.31 -12.0585
CNVI
Conavi Medical Corp.
-0.005 2.13% 0.23 - - 66.65 - 95.30
PINK
Perimeter Medical Imaging AI Inc
-0.015 5.00% 0.28 4.13 - 18.78 11.34 20.22 -2.5521
CHER
Cheelcare Inc.
- -% 1.60 - - 20.92 106.42 21.26

Reports Covered

Stock Research & News

Profile

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

Zero Candida Technologies Inc.

666 Burrard Street, Vancouver, BC, Canada, V6C 3P6

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.